Position in LLY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$369,424
+$94,306 QoQ
Shares Held
308
+20.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#4,006
of 4,605 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Coastwise Capital Group, LLC holds $9,107,252 across 8 Drug Manufacturers - General names. LLY ranks #7 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
80,028 | $1,927,074 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
28,961 | $1,668,732 | |
| 3 | MRK |
Merck & Co., Inc.
|
12,825 | $1,648,012 | |
| 4 | JNJ |
Johnson & Johnson
|
6,189 | $1,571,820 | |
| 5 | AMGN |
Amgen Inc
|
3,206 | $1,160,956 | |
| 6 | ABBV |
AbbVie Inc.
|
1,666 | $419,232 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
308 | $369,424 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,707 | $342,002 |
All Filings in LLY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $369,424 | 308 | Shares | Sole | 2026-07-16 | |
| 2025-12-31 | $275,118 | 256 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||